What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis

Hiroyuki Murai

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	3-4
Number of pages	2
Journal	Clinical and Experimental Neuroimmunology
Volume	6
Issue number	1
DOIs	https://doi.org/10.1111/cen3.12186
Publication status	Published - Feb 1 2015

All Science Journal Classification (ASJC) codes

@article{268f55d96af74909bb996e4b5b8f5535,

title = "What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis",

author = "Hiroyuki Murai",

year = "2015",

month = feb,

day = "1",

doi = "10.1111/cen3.12186",

language = "English",

volume = "6",

pages = "3--4",

journal = "Clinical and Experimental Neuroimmunology",

issn = "1759-1961",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - What should we target? the beginning of a new era in the diagnosis and treatment of myasthenia gravis

AU - Murai, Hiroyuki

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84922126911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922126911&partnerID=8YFLogxK

U2 - 10.1111/cen3.12186

DO - 10.1111/cen3.12186

M3 - Editorial

AN - SCOPUS:84922126911

VL - 6

SP - 3

EP - 4

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

IS - 1

ER -